- AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations
- FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
- Wren Laboratories Announces Discontinuation of NETest 1.0 in Favor of Advanced NETest 2.0
- Boston Scientific Reveals Agreement to Acquire SoniVie Ltd.
- Trinity Biotech Secures Additional Funding for Glucose Monitoring Tech
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
Trinity Biotech Secures Additional Funding for Glucose Monitoring Tech
Trinity Biotech notes the additional liquidity will support both the continued development of their innovative continuous glucose monitoring (CGM) technology and the Company’s comprehensive transformation plan.
WORK Medical Technology Group Partners with Chartwell Medical
Mr. Wu Shuang, CEO and chairman of the board of directors of WORK Medical Technology Group, commented, “We are delighted to enter into a strategic partnership with Chartwell Medical. This collaboration reflects our shared commitment to mutual growth and innovation. By leveraging our combined strengths and resources, we aim to enhance operational efficiency, market leadership, and international competitiveness. In addition, our mutual goal is to advance high-end medical technologies, strengthen competitiveness in the global healthcare industry, and accelerate the adoption of cutting-edge solutions in domestic markets.”
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
“The CHMP’s recommendation for approval of VYJUVEK is an exciting step towards our goal of delivering the first ever corrective therapy to DEB patients across Europe,” said Suma Krishnan, President of Research and Development at Krystal Biotech. “The CHMP’s support for a broad label, including treatment of patients from birth and the option of patient or caregiver administration at home, are also fantastic outcomes for the DEB patients we aim to serve, broadening access and reducing barriers to starting on and staying on therapy.”
TOSS Seal and Cut Bands Combine Precision and Efficiency for Medical Applications
Three key offerings—Beaded Bands, T-Profile Bands, and Custom Seal-Cut (CSC) Bands—stand out for their ability to deliver consistent, reliable seals while cutting polymeric films in a single process. Each band incorporates unique design features and cutting-edge technology tailored to various applications.
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Synaptogenix Announces $5.0 Million Financing
“We are pleased to benefit from the support of our committed long-term investors in this financing,” said Dr. Alan Tuchman, Chief Executive Officer of Synaptogenix. “This capital enhances our ability to be both strategic and opportunistic as we explore potential acquisitions or fund research on innovative assets, all with the goal of driving growth and maximizing value for our shareholders.”
Getinge Completes the Acquisition of Paragonix Technologies
Getinge paid approximately USD 253 million in cash upon completion of the acquisition, on a cash and debt free basis. The earn-out payments are expected to be paid between 2024 and 2026 if agreed upon regulatory and financial performance milestones are achieved and may exceed USD 224 million in aggregate. The initial payout related to the acquisition has been financed through a bridge loan provided by SEB. The acquisition is expected to have a slightly negative impact on Getinge’s adjusted earnings per share in 2024. Getinge anticipates a positive contribution on adjusted earnings per share starting in 2028.
Industry Expert Byline
Reimagining CRM: What’s Next for Medtech Commercial Success | By Akshay Kapadia, CEO and Founder, Conexus Solutions, Inc.
Success depends on more than just choosing the right CRM platform; it requires aligning that platform with optimized business processes, a clear data strategy, and long-term commercial goals. When all of these elements work together, the CRM platform becomes a powerful tool to support growth, innovation, and sustained value.
FDA Medical Device Updates
Huxley Medical’s SANSA Home Sleep Apnea Test Gets FDA Nod
In a clinical trial involving 340 patients across seven institutions, SANSA obtained its initial FDA clearance in 2024, demonstrating its accuracy in comparison to the gold-standard polysomnography. This innovative test incorporates nine distinct physiological channels, such as oximetry, respiratory effort, sleep/wake staging, and a reference electrocardiogram (ECG), into a single patch worn on the chest. This integration allows for a comprehensive understanding of cardiopulmonary health and provides valuable insights.
Our Experts - Byline Articles
Advancements in Imaging
GE HealthCare Advances PET/MR Capabilities with AIR Technologies
Jie Xue, President and CEO of MR at GE HealthCare. “Our latest PET/MR technology will directly impact the most challenging diseases, such as prostate cancer and Alzheimer’s Disease. These diseases require precise and comprehensive imaging for accurate diagnosis, treatment planning, and therapy monitoring. We are excited to see SIGNA PET/MR AIR addressing these challenges and fulfilling our vision of providing access to advanced, personalized care.”
Jun 01, 2023 Philips and Masimo Introduce New, Advanced Monitoring Capabilities to Philips High Acuity Patient Monitors
“Combining our expertise in noninvasive monitoring and signal processing technologies with Philips’ expertise in integrated patient monitoring and therapy solutions is a win-win for patients and clinicians alike,” said Jon Coleman, President of Worldwide OEM Sales and Global Health, Masimo. “We are proud that Philips has chosen to make our innovative SedLine, O3, and NomoLine technologies available to their customers. We look forward to continuing our partnership with a focus on improving patient outcomes and reducing the cost of care.”
Lumicell Announces FDA Acceptance and Priority Review of New Drug Application for LUMISIGHT™ Optical Imaging Agent for Breast Cancer
The Lumicell DVS is an investigational system designed for use in patients with breast cancer to assist in the detection of residual cancerous tissue within the lumpectomy cavity following removal of the primary specimen during breast conserving surgery.
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare - Understanding the Business Side of the Industry and Its Implications
8 Tips to Keep Your Cleanroom Working Properly
A cleanroom is a controlled environment designed to minimize the presence of airborne particles and contaminants, making it crucial for industries such as pharmaceuticals, biotechnology,
Why Delegated Credentialing Matters in Modern Healthcare?
After patient treatment, credentialing is often categorized as the most important procedure for a healthcare provider. The process is vital for onboarding new practitioners and
The Future of Lab Management: Predictions & Trends Shaping the Healthcare Industry
The future of managing labs does carry challenges and risks. However, overall there’s good news for healthcare professionals, the labs themselves, and the many lives
How to Improve EHR Usability to Ensure Better Patient Safety
By now, it has become clear that EHR usability is a complex aspect affecting the tool’s work and the efficiency of medical professionals handling it.
